Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Nature Medicine

Volumn 22, Issue 12, 2016, Pages 1456-1464

  Lee, Jiwon ^a   Boutz, Daniel R ^b   Chromikova, Veronika ^c   Joyce, M Gordon ^d   Vollmers, Christopher ^e   Leung, Kwanyee ^d   Horton, Andrew P ^b   DeKosky, Brandon J ^a,d   Lee, Chang Han ^a   Lavinder, Jason J ^a   Murrin, Ellen M ^a   Chrysostomou, Constantine ^a,f   Hoi, Kam Hon ^a   Tsybovsky, Yaroslav ^a   Thomas, Paul V ^a   Druz, Aliaksandr ^d   Zhang, Baoshan ^d   Zhang, Yi ^d   Wang, Lingshu ^d   Kong, Wing Pui ^a   Park, Daechan ^a   Popova, Lyubov I ^d,g   Dekker, Cornelia L ^h   Davis, Mark M ^h   Carter, Chalise E ⁱ   Ross, Ted M ⁱ   Ellington, Andrew D ^b   Wilson, Patrick C ^g   Marcotte, Edward M ^b   Mascola, John R ^d   Ippolito, Gregory C ^b   Krammer, Florian ^c   Quake, Stephen R ^e,h   Kwong, Peter D ^d   Georgiou, George ^a,b   more..

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e Stanford University   (United States)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CROSS REACTING ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT ANTIBODY; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; VIRUS ANTIBODY;

ADULT; AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; SEASONAL INFLUENZA; SOMATIC MUTATION; SURFACE PLASMON RESONANCE; TANDEM MASS SPECTROMETRY; VIRUS STRAIN; YOUNG ADULT; ANIMAL; B LYMPHOCYTE; CROSS REACTION; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; LIQUID CHROMATOGRAPHY; MALE; ORTHOMYXOVIRIDAE; SEQUENCE ANALYSIS; VACCINE IMMUNOGENICITY;

ADULT; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CHROMATOGRAPHY, LIQUID; CROSS REACTIONS; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGENICITY, VACCINE; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MICE; ORTHOMYXOVIRIDAE; RECEPTORS, ANTIGEN, B-CELL; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84994591811     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4224     Document Type: Article

References (59)

1. Molinari, N.-A. M. et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25, 5086-5096 (2007).
2. Lambert, L. C., Fauci, A. S. Influenza vaccines for the future. N. Engl. J. Med. 363, 2036-2044 (2010).
3. Rimmelzwaan, G. F., McElhaney, J. E. Correlates of protection: novel generations of influenza vaccines. Vaccine 26, D41-D44 (2008).
4. Krammer, F., Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167-182 (2015).
5. Monto, A. S. et al. Comparative efficacy of inactivated and live attenuated influenza vaccines. N. Engl. J. Med. 361, 1260-1267 (2009).
6. Osterholm, M. T., Kelley, N. S., Sommer, A., Belongia, E. A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12, 36-44 (2012).
7. Hobson, D., Curry, R. L., Beare, A. S., Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond. ) 70, 767-777 (1972).
8. Hannoun, C., Megas, F., Piercy, J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 103, 133-138 (2004).
9. Okuno, Y., Isegawa, Y., Sasao, F., Ueda, S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552-2558 (1993).
10. Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856 (2011).
11. Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343-1348 (2012).
12. Li, G.-M. et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA 109, 9047-9052 (2012).
13. Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671 (2008).
14. Moody, M. A. et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One 6, e25797 (2011).
15. Nakamura, G. et al. An in vivo human-plasmablast-enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 14, 93-103 (2013).
16. Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181-193 (2011).
17. Ellebedy, A. H. et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl. Acad. Sci. USA 111, 13133-13138 (2014).
18. Whittle, J. R. R. et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047-4057 (2014).
19. Baz, M. et al. Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada. Emerging Infect. Dis. 18, 1132-1134 (2012).
20. DiLillo, D. J., Palese, P., Wilson, P. C., Ravetch, J. V. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605-610 (2016).
21. Henry Dunand, C. J. et al. Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection. Cell Host Microbe 19, 800-813 (2016).
22. Radigan, K. A., Misharin, A. V., Chi, M., Budinger, G. S. Modeling human influenza infection in the laboratory. Infect. Drug Resist. 8, 311-320 (2015).
23. Wohlbold, T. J. et al. Hemagglutinin stalk-and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice. J. Virol. 90, 851-861 (2015).
24. Whittle, J. R. R. et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108, 14216-14221 (2011).
25. Lee, P. S. et al. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat. Commun. 5, 3614 (2014).
26. Krause, J. C. et al. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85, 10905-10908 (2011).
27. Jackson, K. J. L. et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 16, 105-114 (2014).
28. Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996-1000 (2014).
29. Brodin, P. et al. Variation in the human immune system is largely driven by nonheritable influences. Cell 160, 37-47 (2015).
30. Andrews, S. F. et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci. Transl. Med. 7, 316ra192 (2015).
31. Vollmers, C., Sit, R. V., Weinstein, J. A., Dekker, C. L., Quake, S. R. Genetic measurement of memory B cell recall using antibody repertoire sequencing. Proc. Natl. Acad. Sci. USA 110, 13463-13468 (2013).
32. Lavinder, J. J. et al. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc. Natl. Acad. Sci. USA 111, 2259-2264 (2014).
33. Georgiou, G. et al. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat. Biotechnol. 32, 158-168 (2014).
34. DeKosky, B. J. et al. In-depth determination and analysis of the human paired heavy-and light-chain antibody repertoire. Nat. Med. 21, 86-91 (2015).
35. Boutz, D. R. et al. Proteomic identification of monoclonal antibodies from serum. Anal. Chem. 86, 4758-4766 (2014).
36. Wine, Y., Horton, A. P., Ippolito, G. C., Georgiou, G. Serology in the 21st century: the molecular-level analysis of the serum antibody repertoire. Curr. Opin. Immunol. 35, 89-97 (2015).
37. Sasaki, S. et al. Influence of prior influenza vaccination on antibody and B cell responses. PLoS One 3, e2975 (2008).
38. Andrews, S. F. et al. High pre-existing serological antibody levels correlate with diversification of the influenza vaccine response. J. Virol. 89, 3308-3317 (2015).
39. Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 21, 1065-1070 (2015).
40. Schmidt, A. G. et al. Viral receptor-binding site antibodies with diverse germline origins. Cell 161, 1026-1034 (2015).
41. Godley, L. et al. Introduction of intersubunit disulfide bonds in the membrane-distal region of the influenza hemagglutinin abolishes membrane fusion activity. Cell 68, 635-645 (1992).
42. Iba, Y. et al. Conserved neutralizing epitope at globular head of hemagglutinin in H3N2 influenza viruses. J. Virol. 88, 7130-7144 (2014).
43. Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526-532 (2012).
44. Jain, V. K. et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N. Engl. J. Med. 369, 2481-2491 (2013).
45. Tinoco, J. C. et al. Immunogenicity, reactogenicity and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged 18 years: a phase 3, randomized trial. Vaccine 32, 1480-1487 (2014).
46. Morris, J. A., Kasel, J. A., Saglam, M., Knight, V., Loda, F. A. Immunity to influenza to antibody levels. N. Engl. J. Med. 274, 527-535 (1966).
47. Francis, T. J. On the doctrine of original antigenic sin. Proc. Am. Phil. Soc. 104, 572-578 (1960).
48. DiLillo, D. J., Tan, G. S., Palese, P., Ravetch, J. V. Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc-R interactions for protection against influenza virus in vivo. Nat. Med. 20, 143-151 (2014).
49. McDaniel, J. R., DeKosky, B. J., Tanno, H., Ellington, A. D., Georgiou, G. Ultra-high-throughput sequencing of the immune receptor repertoire from millions of lymphocytes. Nat. Protoc. 11, 429-442 (2016).
50. Cox, J., Michalski, A., Mann, M. Software lock mass by two-dimensional minimization of peptide mass errors. J. Am. Soc. Mass Spectrom. 22, 1373-1380 (2011).
51. Yang, Z. Y. et al. Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope. J. Virol. 78, 4029-4036 (2004).
52. Gillim-Ross, L., Subbarao, K. Emerging respiratory viruses: challenges and vaccine strategies. Clin. Microbiol. Rev. 19, 614-636 (2006).
53. Ross, T. M., Xu, Y., Bright, R. A., Robinson, H. L. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1, 127-131 (2000).
54. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Structural Biology 152, 36-51 (2005).
55. Tang, G. et al. EMAN2: An extensible image processing suite for electron microscopy. Journal of Struct. Biol. 157, 38-46 (2007).
56. Frank, J. et al. SPIDER and WEB: processing and visualization of images in 3d electron microscopy and related fields. J. Struct. Biol. 116, 190-199 (1996).
57. Radermacher, M., Wagenknecht, T., Verschoor, A., Frank, J. Three-dimensional reconstruction from a single-exposure, random conical tilt series applied to the 50S ribosomal subunit of Escherichia coli. J. Microsc. 146, 113-136 (1987).
58. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
59. Shaikh, T. R. et al. SPIDER image processing for single-particle reconstruction of biological macromolecules from electron micrographs. Nat. Protoc. 3, 1941-1974 (2008).